LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Search

Omnicell Inc

Fechado

SetorSaúde

34.36 -1.86

Visão Geral

Variação de preço das ações

24h

Atual

Mín

34

Máximo

34.4

Indicadores-chave

By Trading Economics

Rendimento

-7.5M

-2M

Vendas

3.4M

314M

P/E

Médio do Setor

995.75

61.417

EPS

0.51

Margem de lucro

-0.645

Funcionários

3,580

EBITDA

-9.8M

21M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+69.19% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-427M

1.8B

Abertura anterior

36.22

Fecho anterior

34.36

Sentimento de Notícias

By Acuity

25%

75%

39 / 351 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de mar. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15 de mar. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16 de mar. de 2026, 00:00 UTC

Notícias Principais

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15 de mar. de 2026, 23:45 UTC

Conversa de Mercado

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15 de mar. de 2026, 23:44 UTC

Conversa de Mercado
Notícias Principais

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15 de mar. de 2026, 23:35 UTC

Conversa de Mercado
Notícias Principais

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15 de mar. de 2026, 23:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15 de mar. de 2026, 22:37 UTC

Conversa de Mercado

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15 de mar. de 2026, 22:18 UTC

Conversa de Mercado

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15 de mar. de 2026, 22:00 UTC

Notícias Principais

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 de mar. de 2026, 22:00 UTC

Notícias Principais

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 de mar. de 2026, 03:00 UTC

Notícias Principais

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14 de mar. de 2026, 15:00 UTC

Notícias Principais

Iran War Delivers Windfall to America's Oil Country -- WSJ

14 de mar. de 2026, 02:03 UTC

Ganhos

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 de mar. de 2026, 01:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 de mar. de 2026, 00:29 UTC

Aquisições, Fusões, Aquisições de Empresas

13D Filings -- Barrons.com

13 de mar. de 2026, 22:27 UTC

Conversa de Mercado
Notícias Principais

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 de mar. de 2026, 22:13 UTC

Conversa de Mercado
Notícias Principais

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 de mar. de 2026, 22:04 UTC

Conversa de Mercado
Notícias Principais

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 de mar. de 2026, 22:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

13 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Financial Services Roundup: Market Talk

13 de mar. de 2026, 20:02 UTC

Conversa de Mercado

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 de mar. de 2026, 19:50 UTC

Conversa de Mercado
Notícias Principais

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 de mar. de 2026, 19:35 UTC

Notícias Principais

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

69.19% parte superior

Previsão para 12 meses

Média 58.2 USD  69.19%

Máximo 70 USD

Mínimo 49 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

6

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

39 / 351 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat